Aoxing is involved in developing, manufacturing, as well as distributing narcotic, pain-management, and addiction treatment pharmaceuticals. The company said to make the product available in China market and
Genzyme also reported encouraging early US launch indicators for Aubagio (teriflunomide) such as more than 80% MS specialists prescribing the drug, approximately one in five patients were new
Facility was expanded to accommodate new GMP manufacturing suites and onsite packaging line for larger scale production and cost reduction. Elite chairman and CEO Jerry Treppel said, "Shipping
According to the deal, GVK BIO will deliver a clinical candidate while Endo is responsible for the development and commercialization of the resulting product. GVK BIO CEO Manni
The collaboration will focus on evaluating MCHC’s closed hydroponic cultivation system, plant factory system, developed to grow plants. Medicago’s technologies will be used to produce Nicotiana Benthamiana plants
The $20m new eco-friendly building plant provides space for two new cleanrooms for filter and bag manufacture, labs and offices. Using harvested rainwater and air-handling unit condensate for
The Centricity Practice Solution 11 solution, which features a dynamic search engine, simplifies the data entry required for ambulatory practices to comply with new the ICD-10 coding requirements
Various studies demonstrated a woman’s ability to recognize OAB symptoms, understand vital safety information on the label, judge the necessity of the product use and fittingly use Oxytrol
European patent covers a chemical structure and new chemical process of the chemistry platform technology, developed for therapeutic and cosmetic purpose. Sirona Biochem chief executive officer Neil Belenkie
Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which according to IMS Health data had total sales of $5.3m in the US for the twelve months
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.